Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intra-articular mannitol versus hypertonic dextrose for knee osteoarthritis
IRCT20190912044756N1Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- May 2020
- Modality
- Small Molecules, Inhalation Devices → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in knee osteoarthritis (OA) comparing Mannitol intra-articular injection with Hypertonic dextrose intra-articular injection (2 arms). Primary endpoints: Pain and Activity of daily living. Started May 2020; status: completed.
02
Drugs
Bronchitoldextrose
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on IRCT20190912044756N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190912044756N1.